Alcohol use and dementia: new research directions.


Journal

Current opinion in psychiatry
ISSN: 1473-6578
Titre abrégé: Curr Opin Psychiatry
Pays: United States
ID NLM: 8809880

Informations de publication

Date de publication:
01 03 2021
Historique:
pubmed: 5 1 2021
medline: 18 9 2021
entrez: 4 1 2021
Statut: ppublish

Résumé

Alcohol is gaining increased recognition as an important risk factor for dementia. This review summarises recent evidence on the relationship between alcohol use and dementia, focusing on studies published from January 2019 to August 2020. Epidemiological data continues to yield results consistent with protective effects of low-to-moderate alcohol consumption for dementia and cognitive function. However, recent literature highlights the methodological limitations of existing observational studies. The effects of chronic, heavy alcohol use are clearer, with excessive consumption causing alcohol-related brain damage. Several pathways to this damage have been suggested, including the neurotoxic effects of thiamine deficiency, ethanol and acetaldehyde. Future research would benefit from greater implementation of analytical and design-based approaches to robustly model the alcohol use-dementia relationship in the general population, and should make use of large, consortia-level data. Early intervention to prevent dementia is critical: thiamine substitution has shown potential but requires more research, and psychosocial interventions to treat harmful alcohol use have proven effective. Finally, diagnostic criteria for alcohol-related dementia require formal validation to ensure usefulness in clinical practice.

Identifiants

pubmed: 33394727
doi: 10.1097/YCO.0000000000000679
pii: 00001504-202103000-00015
doi:

Substances chimiques

Protective Agents 0
Ethanol 3K9958V90M

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

165-170

Informations de copyright

Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

Références

Topiwala A, Allan CL, Valkanova V, et al. Moderate alcohol consumption as risk factor for adverse brain outcomes and cognitive decline: longitudinal cohort study. BMJ 2017; 357:j2353.
Schwarzinger M, Pollock BG, Hasan OSM, et al. Contribution of alcohol use disorders to the burden of dementia in France 2008-13: a nationwide retrospective cohort study. Lancet Public Health 2018; 3:e124–e132.
Livingston G, Huntley J, Sommerlad A, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet 2020; 396:413–446.
Han BH, Moore AA, Ferris R, Palamar JJ. Binge drinking among older adults in the United States, 2015 to 2017. J Am Geriatr Soc 2019; 67:2139–2144.
Huhn AS, Hobelmann JG, Ramirez A, et al. Trends in first-time treatment admissions for older adults with alcohol use disorder: Availability of medical and specialty clinical services in hospital, residential, and outpatient facilities. Drug Alcohol Depend 2019; 205:107694.
Roche AM, Kostadinov V. Baby boomers and booze: we should be worried about how older Australians are drinking. Med J Aust 2019; 210:38–39.
Kelly S, Olanrewaju O, Cowan A, et al. Alcohol and older people: a systematic review of barriers, facilitators and context of drinking in older people and implications for intervention design. PLoS One 2018; 13:e0191189.
Anstey KJ, Ee N, Eramudugolla R, et al. A systematic review of meta-analyses that evaluate risk factors for dementia to evaluate the quantity, quality, and global representativeness of evidence. J Alzheimers Dis 2019; 70 (s1):S165–S186.
Rehm J, Hasan OSM, Black SE, et al. Alcohol use and dementia: a systematic scoping review. Alzheimers Res Ther 2019; 11:1.
Grønkjær M, Flensborg-Madsen T, Osler M, et al. Adult-life alcohol consumption and age-related cognitive decline from early adulthood to late midlife. Alcohol Alcohol 2019; 54:446–454.
Liu Y, Mitsuhashi T, Yamakawa M, et al. Alcohol consumption and incident dementia in older Japanese adults: The Okayama Study. Geriatr Gerontol Int 2019; 19:740–746.
Zhang R, Shen L, Miles T, et al. Association of low to moderate alcohol drinking with cognitive functions from middle to older age among US adults. JAMA Netw Open 2020; 3:e207922-e.
Koch M, Fitzpatrick AL, Rapp SR, et al. Alcohol consumption and risk of dementia and cognitive decline among older adults with or without mild cognitive impairment. JAMA Netw Open 2019; 2:e1910319-e.
Xu W, Wang H, Wan Y, et al. Alcohol consumption and dementia risk: a dose–response meta-analysis of prospective studies. Eur J Epidemiol 2017; 32:31–42.
Brennan SE, McDonald S, Page MJ, et al. Long-term effects of alcohol consumption on cognitive function: A systematic review and dose-response analysis of evidence published between 2007 and 2018. Syst Rev 2020; 9:1–39.
Day GS, Cruchaga C, Wingo T, et al. Association of acquired and heritable factors with intergenerational differences in age at symptomatic onset of Alzheimer disease between offspring and parents with dementia. JAMA Netw Open 2019; 2:e1913491-e.
Kivimäki M, Singh-Manoux A, Batty GD, et al. Association of alcohol-induced loss of consciousness and overall alcohol consumption with risk for dementia. JAMA Netw Open 2020; 3:e2016084-e.
Rao R, Topiwala A. Alcohol use disorders and the brain. Addiction 2020; 115:1580–1589.
Rao R, Schofield P, Ashworth M. Alcohol use, socioeconomic deprivation and ethnicity in older people. BMJ Open 2015; 5:e007525.
Melberg HO. Elster J, Gjelsvik O, Hylland A, Moene K. Does moderate alcohol intake reduce mortality? Understanding choice, explaining behaviour: Essays in honour of Ole-Jorgen Skog.. Oslo: Oslo Academic Press; 2006. 191–210.
Au Yeung SL, Jiang CQ, Cheng KK, et al. Evaluation of moderate alcohol use and cognitive function among men using a Mendelian randomization design in the Guangzhou biobank cohort study. Am J Epidemiol 2012; 175:1021–1028.
McQuire C, de Vocht F. Methodological advances to mitigate some of the challenges of research on alcohol and all-cause mortality: Commentary on Rehm. Drug Alcohol Rev 2019; 38:7–8.
Benedetto U, Head SJ, Angelini GD, Blackstone EH. Statistical primer: propensity score matching and its alternatives. Eur J Cardiothorac Surg 2018; 53:1112–1117.
Brookhart MA, Wyss R, Layton JB, Stürmer T. Propensity score methods for confounding control in nonexperimental research. Circ Cardiovasc Qual Outcomes 2013; 6:604–611.
Naimi AI, Cole SR, Kennedy EH. An introduction to g methods. Int J Epidemiol 2017; 46:756–762.
Mansournia MA, Etminan M, Danaei G, et al. Handling time varying confounding in observational research. BMJ (Online) 2017; 359 (October):
Larsson SC, Traylor M, Malik R, et al. Modifiable pathways in Alzheimer's disease: Mendelian randomisation analysis. BMJ (Clinical research ed) 2017; 359:j5375-j.
Andrews SJ, Goate A, Anstey KJ. Association between alcohol consumption and Alzheimer's disease: A Mendelian randomization study. Alzheimers Dement 2020; 16:345–353.
Nixon SJ, Lewis B. Clarifying the neurobehavioral sequelae of moderate drinking lifestyles and acute alcohol effects with aging. Int Rev Neurobiol 2019; 148:39–78.
Topiwala A, Ebmeier KP. Effects of drinking on late-life brain and cognition. Evidence-Based Mental Health 2018; 21:12–15.
Kim JW, Byun MS, Yi D, et al. Association of moderate alcohol intake with in vivo amyloid-beta deposition in human brain: A cross-sectional study. PLoS Med 2020; 17:e1003022.
Koch M, Costanzo S, Fitzpatrick AL, et al. Alcohol consumption, brain amyloid-β deposition, and brain structural integrity among older adults free of dementia. J Alzheimers Dis 2020; 74:509–519.
Immonen S, Launes J, Järvinen I, et al. Moderate alcohol use is associated with decreased brain volume in early middle age in both sexes. Sci Rep 2020; 10:1–8.
Rao RT, Draper B. Addressing alcohol-related dementia should involve better detection, not watchful waiting. Br J Psychiatry 2018; 212:67–68.
Ridley NJ, Draper B, Withall A. Alcohol-related dementia: an update of the evidence. Alzheimers Res Ther 2013; 5:1–8.
Oslin D, Atkinson RM, Smith DM, Hendrie H. Alcohol related dementia: proposed clinical criteria. Int J Geriatr Psychiatry 1998; 13:203–212.
Stavro K, Pelletier J, Potvin S. Widespread and sustained cognitive deficits in alcoholism: a meta-analysis. Addict Biol 2013; 18:203–213.
Listabarth S, König D, Vyssoki B, Hametner S. Does thiamine protect the brain from iron overload and alcohol-related dementia? Alzheimers Dement 2020.
Chou WP, Chang YH, Lin HC, et al. Thiamine for preventing dementia development among patients with alcohol use disorder: a nationwide population-based cohort study. Clin Nutr 2019; 38:1269–1273.
Joshi AU, Van Wassenhove LD, Logas KR, et al. Aldehyde dehydrogenase 2 activity and aldehydic load contribute to neuroinflammation and Alzheimer's disease related pathology. Acta Neuropathol Commun 2019; 7:190.
Zhang K, Luo J. Role of MCP-1 and CCR2 in alcohol neurotoxicity. Pharmacol Res 2019; 139:360–366.
Melbourne JK, Thompson KR, Peng H, Nixon K. Its complicated: The relationship between alcohol and microglia in the search for novel pharmacotherapeutic targets for alcohol use disorders. Prog Mol Biol Transl Sci 2019; 167:179–221.
Mira RG, Lira M, Tapia-Rojas C, et al. Effect of alcohol on hippocampal-dependent plasticity and behavior: role of glutamatergic synaptic transmission. Front Behav Neurosci 2020; 13:1–15.
Mira RG, Tapia-Rojas C, Perez MJ, et al. Alcohol impairs hippocampal function: From NMDA receptor synaptic transmission to mitochondrial function. Drug Alcohol Depend 2019; 205:1–10.
Calabro M, Mandelli L, Crisafulli C, et al. Psychiatric disorders and SLC6A4 gene variants: possible effects on alcohol dependence and alzheimer's disease. Mol Biol Rep 2020; 47:191–200.
Evangelou E, Gao H, Chu C, et al. New alcohol-related genes suggest shared genetic mechanisms with neuropsychiatric disorders. Nat Hum Behav 2019; 3:950–961.
Pruckner N, Baumgartner J, Hinterbuchinger B, et al. Thiamine substitution in alcohol use disorder: a narrative review of medical guidelines. Eur Addict Res 2019; 25:103–110.
Day E, Bentham PW, Callaghan R, et al. Thiamine for prevention and treatment of Wernicke-Korsakoff Syndrome in people who abuse alcohol. Cochrane Database Syst Rev 2013; 7:CD004033.
Magill M, Ray L, Kiluk B, et al. A meta-analysis of cognitive-behavioral therapy for alcohol or other drug use disorders: Treatment efficacy by contrast condition. J Consult Clin Psychol 2019; 87:1093.
Angus C, Latimer N, Preston L, et al. What are the implications for policy makers? A systematic review of the cost-effectiveness of screening and brief interventions for alcohol misuse in primary care. Front Psychiatry 2014; 5:114.
Fein G, McGillivray S. Cognitive performance in long-term abstinent elderly alcoholics. Alcohol Clin Exp Res 2007; 31:1788–1799.
Seddon JL, Wadd S, Wells E, et al. Drink wise, age well; reducing alcohol related harm among people over 50: a study protocol. BMC Public Health 2019; 19:240.
Bright SJ, Williams CM. Development of Australia's first older adult-specific early intervention for alcohol-related harm: Feasibility and proof of concept. Australas J Ageing 2017; 36:52–55.

Auteurs

Rachel Visontay (R)

Centre for Healthy Brain Ageing, University of New South Wales, Sydney, Australia.
The Matilda Centre for Research in Mental Health and Substance Use, The University of Sydney, Sydney, Australia.

Rahul Tony Rao (RT)

Department of Old Age Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, King's College London, United Kingdom.

Louise Mewton (L)

Centre for Healthy Brain Ageing, University of New South Wales, Sydney, Australia.
The Matilda Centre for Research in Mental Health and Substance Use, The University of Sydney, Sydney, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH